The expression of EFNA1 was high in bladder urothelial carcinoma (BLCA), EFNA2 was highest in stomach adenocarcinoma (STAD), and EFNA3 was highest in lung squamous cell carcinoma (LUSC). Here, EFNA2 is linked to bladder transitional cell carcinoma.